# Anda Biotechnology

Personalized tumor neoantigen therapies and AI-assisted drug development



Canonical: https://uniquebase.ai/companies/UB-C6779
Stable identifier: UB-C6779
Snapshot captured: 2026-10-15T18:31:01.470Z
English updated: 2026-10-15T20:35:58.668Z

## Funding

Listed 4 records.

- 2026-08-01 · Undisclosed · Series A+ · 北京昌平产业发展投资基金（有限合伙）, 合肥国生未来科转创业投资基金合伙企业（有限合伙）, 安徽洪泰合康一期创业投资基金合伙企业（有限合伙）, 肥西紫蓬创业投资合伙企业（有限合伙）
  > On 2026-08-01, according to Xiniu Data, Anda Biotechnology completed Series A+ financing for an undisclosed amount. Investors were lead investor Anhui Hongtaihekang Phase One Venture Capital Fund Partnership (Limited Partnership), participating investor Beijing Changping Industry Development Investment Fund (Limited Partnership), participating investor Feixizipeng Venture Capital Partnership (Limited Partnership), participating investor Hefei Guoshengweilaikezhuan Venture Capital Fund Partnership (Limited Partnership). The company is a developer of personalized oncology neoantigen vaccines. (translated source brief)
- 2026-04-10 · Undisclosed · Equity · 共青城坤元投资合伙企业, 共青城坤元投资合伙企业（有限合伙）
  > On 2026-04-10, according to Xiniu Data, Anda Biotechnology completed equity financing for an undisclosed amount. The investor was Gongqingcheng Kunyuan Investment Partnership (Limited Partnership). The company develops personalized tumor neoantigen vaccines. (translated source brief)
- 2025-07-07 · Undisclosed · Strategic · 泰格医药
- 2025-03-24 · Tens of millions · Series A · 力鼎资本, 博通创投, 司南园科, 德丰杰龙脉基金, 浦信资本

## Valuation

Listed 4 records.

- 2026-08-01 · amount unavailable · Series A+ · 北京昌平产业发展投资基金（有限合伙）, 合肥国生未来科转创业投资基金合伙企业（有限合伙）, 安徽洪泰合康一期创业投资基金合伙企业（有限合伙）, 肥西紫蓬创业投资合伙企业（有限合伙）
  > On 2026-08-01, according to Xiniu Data, Anda Biotechnology completed Series A+ financing for an undisclosed amount. Investors were lead investor Anhui Hongtaihekang Phase One Venture Capital Fund Partnership (Limited Partnership), participating investor Beijing Changping Industry Development Investment Fund (Limited Partnership), participating investor Feixizipeng Venture Capital Partnership (Limited Partnership), participating investor Hefei Guoshengweilaikezhuan Venture Capital Fund Partnership (Limited Partnership). The company is a developer of personalized oncology neoantigen vaccines. (translated source brief)
- 2026-04-10 · amount unavailable · Equity · 共青城坤元投资合伙企业, 共青城坤元投资合伙企业（有限合伙）
  > On 2026-04-10, according to Xiniu Data, Anda Biotechnology completed equity financing for an undisclosed amount. The investor was Gongqingcheng Kunyuan Investment Partnership (Limited Partnership). The company develops personalized tumor neoantigen vaccines. (translated source brief)
- 2025-07-07 · amount unavailable · Strategic · 泰格医药
- 2025-03-24 · amount unavailable · Series A · 力鼎资本, 博通创投, 司南园科, 德丰杰龙脉基金, 浦信资本

## Revenue

No revenue records are listed yet.


## Team

No published team profiles are linked yet.

## Products

No published products profiles are linked yet.

## Investors

- [共青城坤元投资合伙企业](/institutions/gongqingchengkunyuan-investment-partnership)
- [共青城坤元投资合伙企业（有限合伙）](/institutions/gongqingchengkunyuan-investment-partnership-limited-partnership)
- [力鼎资本](/institutions/liding-capital)
- [北京昌平产业发展投资基金（有限合伙）](/institutions/beijing-changping-industry-development-investment-fund-limited-partnership)
- [博通创投](/institutions/botong-venture-capital)
- [司南园科](/institutions/sinanyuanke)
- [合肥国生未来科转创业投资基金合伙企业（有限合伙）](/institutions/hefei-guoshengweilaikezhuan-venture-capital-fund-partnership-limited-partnership)
- [安徽洪泰合康一期创业投资基金合伙企业（有限合伙）](/institutions/anhui-hongtaihekang-phase-one-venture-capital-fund-partnership-limited-partnership)
- [德丰杰龙脉基金](/institutions/defengjielongmai-fund)
- [泰格医药](/institutions/taige-pharmaceutical)
- [浦信资本](/institutions/puxin-capital)
- [肥西紫蓬创业投资合伙企业（有限合伙）](/institutions/feixizipeng-venture-capital-partnership-limited-partnership)

## Sources

- No source links are available for this profile.